Our aim is simple: to positively impact lives, together. Using the power of science and innovation, our people improve the impact medicine has on patients. Together, we explore the limitless world of science through our impressive product pipeline and we take our understanding of many therapeutic areas to a whole new level by seeking new treatments.
Who are we
With such essential, life-changing work being undertaken across the world, the range of roles we offer is extensive. From Regulatory and Medical Affairs to Finance, Manufacturing, and Supply, our opportunities cover many disciplines. Here, you can explore the full potential of science while building a career that means more to you and our patients.
We are OTDP Pharmaceuticals, one of the world’s most forward-thinking and connected Pharmaceutical companies. With a strong purpose, an even stronger bond between each of our people, and a science-led, patient-first attitude, we’re changing the future of medicine and the impact it can have on lives across the globe. Are you ready for a challenge?
The global pharmaceuticals market is vast. The Middle East remains a priority market for growth with other key growth areas including emerging markets and Asia Pacific regions.
This trend of increasing demand is expected to continue as the world’s population grows, economies in the emerging markets become more prosperous, and global changes in lifestyles affect long-term health.
Our strategy is to research and produce innovative, high-quality, and needed medicines; making these as accessible as possible to countries at all levels of income and development. To do this we focus on creating a strong differentiated pipeline, leading in Nervous and respiratory, and developing our presence in specialty therapy areas The journey to discovering and developing new medicines is lengthy, expensive, and subject to a high rate of failure. Learn more about our research and development.
We are exploring different approaches to promote – and speed up – innovation in our labs. Having broken down the traditional, R&D model, our scientists now work in smaller units focused on specific areas of research. This encourages greater entrepreneurialism and accountability. These groups are tasked with seeking out the biological targets involved in disease and creating molecules or biopharmaceuticals that will ultimately become new medicines.
We also know that we won’t discover everything inside our own labs and that we need to partner with other companies, academic institutions, and research charities. We currently have research collaborations with more than 127 external organizations.